A/Prof Leslie Reti AM – Chair
Dr Leslie Reti is a Director on the Board of the Peter MacCallum Cancer Centre, he is the Chair of the Quality Committee and a member of the Research Committee.
Dr Reti has a long experience in corporate and clinical governance.
He was an executive member of the Victorian Council on Safety and Quality in Health and has been Chair of the QA Committee at The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). He received the 2013 RANZCOG Distinguished Service Medal.
In 2018 he received a Membership (AM) of the Order of Australia for significant service to Women’s Health and to the community. In 2019 he was awarded the Australian Council on Hospital Standards Medal.
Dr Reti was also named the recipient of the 2013 Victorian Public Healthcare Lifetime Achievement Award.
Ms Siegi Schmidmaier – Director
Ms Siegi Schmidmaier is an executive with Silver Chain Group, a national provider of home based health and aged care. Siegi leads the strategy portfolio that includes innovation, digital futures, communications, and partnerships. She has held a number of executive leadership roles including the Executive Director of Strategy at the Peter MacCallum Cancer Centre, where she sponsored pathology and led the clinical and academic team in conceptualising the national Centre of Excellence in Cell Therapies.
Ms Schmidmaier has a strong interest in creating new projects and business units that introduce new technology, innovation and a commercial focus to the traditional clinical and medical technology setting.
Previously, Ms Schmidmaier held roles with the Department of Prime Minister and Cabinet, Victorian Minister for Health, Victorian Department of Health and Ageing, and an international consulting firm.
Ms Schmidmaier is a Graduate of the Australian Institute of Company Directors, has a Master of Science (Public Health), a Bachelor of Nursing, and Graduate Diploma of Project Management.
Mr Peter Turvey – Director
Mr. Turvey has had more than 30 years experience in the biotech/pharmaceutical industry having been former Executive Vice- President Licensing, Group General Counsel and Company Secretary of global biopharmaceutical company CSL Limited, retiring in 2011. Mr Turvey is currently a non-executive director of ASX listed Starpharma Holdings Ltd as well as the Chair of its Audit and Risk Committee, and non-executive director of the Victorian Government-owned entities Agriculture Victoria Services Pty. Ltd. and Phytogene Pty Ltd and the oncolytic virus research company Immvirx Pty. Ltd.
Mr Turvey played a key role in the transformation of CSL from a government-owned entity , through ASX-listing in 1994 to a global plasma biopharmaceutical company. He also had responsibility for the protection and licensing of CSL’s intellectual property and for risk management within CSL, which included management of the internal audit function as well as being Chairman of the Corporate Risk Management Committee.
Mr Matt O’Keefe – Director
Matt O’Keefe is a Board Director of the Peter MacCallum Cancer Centre and the Chairman of the Finance Committee.
Mr O’Keefe is a Partner and the ASPAC Cyber Leader at KPMG. With more than 25 years’ technology, finance and assurance experience, Mr O’Keefe specialises in technology advisory and provides a range of services across technology governance and risk, project management, IT strategy and performance, and information security.
Mr O’Keefe has contributed to community organisations, including Breast Cancer Network Australia (BCNA), over more than 10 years, and holds a position of Chairman of the Victorian Association for The Care & Resettlement of Offenders (VACRO).